Cytokinetics reported $6.83M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 166.33M 17.95M Jun/2026
Amgen USD 10.23B 1.09B Jun/2026
Bayer EUR 18.55B 4.36B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Brainstorm Cell Therapeutics USD 122K 36K Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Capricor Therapeutics USD 59K 0 Dec/2025
Cytokinetics USD 6.83M 10.94M Mar/2026
Eisai JPY 253.13B 26.12B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Exelixis USD 328.95M 42.03M Mar/2026
Geron USD 44.1M 4.87M Mar/2026
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 492M 10M Jun/2026